Document Type : Original Article

Authors

1 Department of Pharmacy Practice, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, India

2 Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Objective: This study aims at the outcome of providing pharmaceutical care service for 
asthma patients through an active partnership between clinical pharmacist and patients, for 
an optimal pharmacotherapy and a better quality of life (QoL).
Methods: In this controlled clinical trial, which was conducted for 8 months (2009) in 
the Institute of Pulmonary Medicine and Research Centre of a 550-bedded multispecialty 
tertiary care teaching hospital in India, all patients diagnosed with asthma at least 6 months 
before getting enrolled in this study were included (n = 66). Patients were divided into the 
intervention group who received pharmaceutical care through asthma education, medication 
counselling, instructions on lifestyle modifications, asthma care diary, etc., and the control 
group who were not provided any pharmaceutical care. Asthma control in the two groups 
was assessed using Asthma Control Test (ACT) at regular intervals. QoL in both groups was 
assessed at regular intervals using standardized Asthma Quality of Life Questionnaire (AQLQ). 
Findings: The mean AQLQ scores for the intervention group at the baseline were changed 
to significantly higher amounts in the final visit indicating overall, activity, symptoms, emotional, 
and environmental domains, respectively (P < 0.05). The mean ACT scores for intervention 
group at baseline were also increased in statistically significant amounts in the final visit for 
all the five ACT questions (P < 0.05). 
Conclusion: Our pharmaceutical care program showed a positive impact in improving 
patient’s asthma-related QoL, lung function, and asthma control. By providing structured 
pharmaceutical care, clinical pharmacists can help asthma patients to achieve desired health 
outcomes.

Keywords

  1. Rene-Henri N, Khamla Y, Nadaira N, Ouellet C, Blais L, 
    Lalonde L, et al. Community pharmacists’ interventions 
    in asthma care: a descriptive study. Ann Pharmacother 
    2009;43:104-11.
    2. Koda-Kimble MA. Applied therapeutics: The clinical use 
    of drugs. Vol. 23. Philadelphia: Wolters Kluwer/Lippincott 
    Williams & Wilkins; 2009. p. 1-43.
    3. Thorsteinsdottir B, Volcheck GW, Enemark Madsen B, Patel 
    AM, Li JT, Lim KG. The ABCs of asthma control. Mayo Clin 
    Proc 2008;83:814-20.
    4. Chotirmall SH, Watts M, Branagan P, Donegan CF, Moore 
    A, McElvaney NG. Diagnosis and management of asthma in 
    older adults. J Am Geriatr Soc 2009;57:901-9.
    5. Ponieman D, Wisnivesky JP, Leventhal H, Musumeci-Szabó 
    TJ, Halm EA. Impact of positive and negative beliefs about 
    inhaled corticosteroids on adherence in inner-city asthmatic 
    patients. Ann Allergy Asthma Immunol 2009;103:38-42.
    6. Hepler CD, Strand LM. Opportunities and responsibilities in 
    pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
    7. ASHP statement on the role of the pharmacist in patientfocused care. American Society of Health-System Pharmacists. 
    Am J Health Syst Pharm 1995;52:1808-10.
    8. Anita K, Chabra SK, Vijayan VK. Assessing Asthma 
    Management in An Urban Community In Delhi India. Value 
    Health 2009;12:129.
    9. Saini B, Filipovska J, Bosnic-Anticevich S, Taylor S, Krass I, 
    Armour C. An evaluation of a community pharmacy-based 
    rural asthma management service. Aust J Rural Health 
    2008;16:100-8.
    10. Shah S, Roydhouse JK, Sawyer SM. Asthma education in 
    primary healthcare settings. Curr Opin Pediatr 2008;20:705-10.
  2. 11. Armour C, Bosnic-Anticevich S, Brillant M, Burton D, 
    Emmerton L, Krass I, et al. Pharmacy Asthma Care Program 
    (PACP) improves outcomes for patients in the community. 
    Thorax 2007;62:496-502.
    12. Bunting BA, Cranor CW. The Asheville Project: long-term 
    clinical, humanistic, and economic outcomes of a communitybased medication therapy management program for asthma. 
    J Am Pharm Assoc (2003) 2006;46:133-47.
    13. Charrois T, Newman S, Sin D, Senthilselvan A, Tsuyuki RT. 
    Improving asthma symptom control in rural communities: 
    the design of the Better Respiratory Education and Asthma 
    Treatment in Hinton and Edson study. Control Clin Trials 
    2004;25:502-14.
    14. Mangiapane S, Schulz M, Mühlig S, Ihle P, Schubert I, 
    Waldmann HC. Community pharmacy-based pharmaceutical 
    care for asthma patients. Ann Pharmacother 2005;39:1817-22.
    15. Jensen MP. Questionnaire validation: a brief guide for readers 
    of the research literature. Clin J Pain 2003;19:345-52.
    16. Williams A. How to...write and analyse a questionnaire. 
    J Orthod 2003;30:245-52.
    17. Abdelhamid E, Awad A, Gismallah A. Evaluation of a hospital 
    pharmacy-based pharmaceutical care services for asthma 
    patients. Pharm Pract 2008;6:25-32.
    18. Pereira ED, Cavalcante AG, Pereira EN, Lucas P, Holanda MA. 
    Asthma control and quality of life in patients with moderate 
    or severe asthma. J Bras Pneumol 2011;37:705-11.
    19. Ko FW, Hui DS, Leung TF, Chu HY, Wong GW, Tung AH, et al. 
    Evaluation of the asthma control test: a reliable determinant 
    of disease stability and a predictor of future exacerbations. 
    Respirology 2012;17:370-8.
    20. Mancuso CA, Sayles W, Allegrante JP. Randomized trial of 
    self-management education in asthmatic patients and effects 
    of depressive symptoms. Ann Allergy Asthma Immunol 
    2010;105:12-9.
    21. Mancuso CA, Sayles W, Allegrante JP. Knowledge, attitude, 
    & self efficacy in asthma self-management and quality of life. 
    J Asthma 2010;47:883-8.
    22. Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans 
    L, Remon JP, et al. Effectiveness of pharmacist intervention 
    for asthma control improvement. Eur Respir J 2008;31:790-9.
    23. Santos Dde O, Martins MC, Cipriano SL, Pinto RM, Cukier A, 
    Stelmach R. Pharmaceutical care for patients with persistent 
    asthma: assessment of treatment compliance and use of 
    inhaled medications. J Bras Pneumol 2010;36:14-22.